Categories: News

Alvalux Medical and its U.S. Subsidiary CicaLux Inc. Awarded Patent

SAN DIEGO and LIEGE, Belgium, March 30, 2021 /PRNewswire/ — Alvalux Medical, a Belgian medtech wearables company, and its USA subsidiary CicaLux Inc., has been awarded its first patent from the United States Patent and Trademark Office for its CicaLux® product line. The invention (U.S. Patent 10,953,238) is an award-winning, wearable dermal repair system that delivers energized combination therapy to treat skin-related conditions, diseases and disorders.   

“This patent supports our first award-winning product, CicaLux Energized Scar-Care, a new scar therapy treatment at the crossroads of aesthetic care and wearable technology that is focused on helping the approximately 250 million people per year who undergo incisional surgeries,” says Michel Alvarez, CEO and inventor. “Its broad claims also cover an exciting CicaLux branded pipeline, ranging from anti-aging, stretch mark and acne treatments to photo-dynamic therapies for skin cancer, psoriasis and advanced wound care.”

This CE-marked and FDA-registered, eco-friendly wearable device marketed as CicaLux Energized Scar-Care features proprietary, non-invasive Triple Action Therapy, which combines the benefits of hydration, heat and compression therapy. It helps improve old and prevent new hypertrophic and keloid scar healing, flatten and minimize old and new scars, improve skin’s color and texture, relieve pain and itchiness, and reduce tension and numbness following C-sections, hysterectomies, tummy tucks, breast augmentation and other incisional surgeries. It is applicable to all skin types.

MSRP is US$89.00 per kit, which provides 60 days of therapy. Get CicaLux Energized Scar Care at CicaLux.us, Amazon, Walmart.com, Verishop.com and other retailers. To learn more, visit www.cicalux.us for USA, or www.cicalux.com for the European Union.

USA retailers interested in partnering with CicaLux can contact Pro Beauty Partners at 310-230-5410 or info@probeautypartners.com. For USA medical professionals, salon and spa sales inquiries, contact Alan Ehrlich at allen@alvalux.com. For international distribution and licensing inquiries, contact Marie-Noelle Thyrion at marie@alvalux.com.

About CicaLux Inc. USA
California entrepreneur Michel Alvarez, CEO and creator, founded CicaLux Inc. USA to bring CicaLux-branded wearable medical devices to consumers and patients around the world. Award-winning CicaLux is available in the United States, European Union, United Kingdom, Switzerland, Australia, Hong Kong, Egypt and Columbia, with more countries in the registration process. Visit www.cicalux.com and www.cicalux.us for more information.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/alvalux-medical-and-its-us-subsidiary-cicalux-inc-awarded-patent-for-wearable-medical-devices-that-provide-non-invasive-dermal-repair-301258378.html

SOURCE Alvalux Medical

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

10 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

10 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago